We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




ICU Discharge Policies May Bias Hospital Quality Measurement

By HospiMedica International staff writers
Posted on 12 Jun 2012
A new study suggests that while in-hospital mortality for intensive care unit (ICU) patients is often used as a quality measure, discharge practices may bias the results in a way that disadvantages large academic hospitals.

Researchers at the University of Pittsburgh School of Medicine (PA, USA) conducted a retrospective cohort study using data on 43,830 ICU patients admitted to 134 hospitals in the state of Pennsylvania in 2008. More...
Discharge bias was defined as 30-day ICU mortality minus in-hospital mortality. The results showed that the mean risk-adjusted hospital-specific 30-day and in-hospital mortality rates were 13.1% and 9.6%, respectively, resulting in a mean hospital-specific discharge bias of 3.5%. Discharge bias was greater in small hospitals, nonteaching hospitals, and hospitals with fewer commercial health maintenance organization (HMO) patients.

The discharge bias resulted in these facilities appearing relatively better in quality compared to large teaching hospitals, or those with a high proportion of commercial HMO patients. Hospital rank was also greatly affected by discharge bias, with 29.1% of hospitals increasing in rank by at least one quartile and 26.9% decreasing in rank by at least one quartile. Large teaching hospitals and hospitals with the highest proportion of HMO patients were more likely to decrease in rank than small, nonteaching hospitals or hospitals with a lower proportion of HMO patients. The study was presented at the American Thoracic Society 2012 International Conference, held during May 2012 in San Francisco (CA, USA).

“Mortality measures tied to a specific time point, such as 30-day mortality, are less biased by discharge practices, but are harder to calculate,” said lead author and study presenter Lora Reineck, MD. “State and national programs that use in-hospital mortality to benchmark hospitals should note how discharge bias unfairly disadvantages certain types of hospitals; accounting for this bias might prevent these hospitals from being unfairly penalized in public reporting or pay-for-performance programs.”

Related Links:
University of Pittsburgh School of Medicine



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.